$GILD I’m an M. D. This study says Remy helps but doesn’t cure. I’m going to keep my comments here solely relevant to $$/stock strategy. Basically it’s best for every patient who needs oxygen, which is most hospitalized patients. Doctors are going to put nearly EVERY patient with Covid on Remy. To me this translates into a 100 million people(minimum)worldwide probably qualifying for Remy. All we need is another treatment approved. I personally don’t understand why this stock isn’t rocking already but I’ll be holding a very large position going into the Fall.